Clinical Trial Update: Efficacy and Safety of Enisamium Iodide for the Treatment of Acute Respiratory Viral Infections, Including Influenza. [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 clinical trials evaluated enisamium iodide for acute respiratory viral infections, including influenza, with results posted after completion…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Viral Infection

Drugs mentioned

• Enisamium iodide (enisamium iodide)

Snippet

Sponsor: Joint Stock Company "Farmak" | Conditions: Acute Respiratory Viral Infections, Human Influenza | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2026-01-08